FREE SHIPPING FOR ORDERS OVER £50!

L-THEANINE BENEFITS

KEY BENEFITS OF L-THEANINE

    • Supports stress resilience
    • Supports relaxed mood
    • Supports general immune health
    • Supports cognitive function
    • Supports sleep

ABOUT L-THEANINE

In green tea, L-theanine naturally occurs as a calming amino acid. Hence, it can be considered a nootropic as it supports focused attention, mental alertness, and calm, relaxed feelings of mental energy.

 

The combination of L-theanine and caffeine is often used in nootropic stacks, since it supports focus, accuracy, and task switching.

 

Alpha brain waves (A-waves), which are considered markers of relaxation[1], are promoted by L-theanine. During this brain state, stress is decreased.

 

There are a few other effects associated with L-theanine. Glutamate, one of the building blocks for glutamatergic signaling, can be made from L-theanine. It is an antioxidant that contributes to detoxification and glutamate is one of the building blocks for glutamate.

 

Because of another metabolite, L-theanine serves to prime specialized immune cells - gamma delta T cells - that enhance immune memory* and response to new antigens.

 

L-theanine is the most abundant amino acid in green and black tea leaves (made from the Camellia sinensis plant): tea leaves contain up to 50% of the amino acid L-theanine.

L-THEANINE FULL BENEFITS

Brain Function

 

  • Supports attention[3–5]
  • Supports memory[4–7]
  • Supports learning[8]
  • Supports executive function[4,9]
  • Supports faster reaction times[3]
  • Supports alpha (α) brain waves (α-waves are associated with relaxation, selective attention, and mental alertness)[1,3,10–13]
  • Supports hippocampal activity[14]
  • Supports dopamine signaling[15–21]
  • Supports serotonin signaling[21]
  • Supports GABA levels in the brain[21]
  • Binds to glutamate receptors (with low affinity)[22–24]
  • Supports hippocampal neurogenesis[6]
  • Supports brain-derived neurotrophic factor (BDNF)[6,24,25] 
  • Supports neuroprotective functions[7,8,26–28]

 

Mood and Stress

 

  • Supports a calm/relaxed mood[4,8,9,13,14,29–32]
  • Supports a positive mental-emotional bias[4,9]
  • Supports psychological and physiological stress responses[33]
  • Supports healthy behavioral and cognitive responses to stress[26,34]
  • Reduces fight or flight nervous system activity (i.e., promotes relaxation response)[33]

 

Sleep

 

  • Supports sleep efficiency and quality[4,9,35,36]
  • Counters some of caffeine’s effects on deep sleep[37]

 

Immune function

 

  • Supports general immune health[38–40]
  • Supports post-exercise immunity[41–44]
  • Supports innate immunity[42,45,46]
  • Supports adaptive immunity[42,46,47]
  • Supports immune signaling[42,48]
  • Supports healthy gamma delta (γδ) T cell function[49,50]
  • Supports healthy dendritic cell function[45]
  • Supports healthy natural killer cell function[41,42,49,51]
  • Supports healthy neutrophil function[43,44,52]
  • Supports healthy mast cell function[46]
  • Supports healthy B cell function[51,53,54]

 

Gastrointestinal Function

 

  • Supports gut microbiota[55]
  • Supports amino acid absorption[56]

 

Healthy aging

 

  • Pro-longevity (Caenorhabditis elegans)[57]

 

Sleep

 

  • Supports sleep efficiency and quality[4,9,35,36]
  • Counters some of caffeine’s effects on deep sleep[37]

 

Complementary ingredients

 

  • Caffeine in cognitive performance[58–61]
  • GABA for supporting sleep quality[62]
  • L-Cysteine in support of general immune health[38,41,43,44,51,53,63]
  • Green tea extracts in support of general immune health[39,40]

L-THEANINE CAN BE FOUND IN:

Morning Momentum

Get Instant Access To A Simple, Proven System That Has Helped

THOUSANDS of People

IGNITE Their Health and Energy

to Create The Life They Deserve!

Learn More

START HERE

 

OPTIMUM MIND PERFORMANCE

 

Optimum Health (Foundation)

 

Cleanse, Clear & Rejuvenate

 

Internal Body Balance

 

Build Healthy Cells

 

Fuel Your Mind & Body

 

Protect: Longevity & Immunity

 

Enhance: Biohacking

 

REFERENCES

[1] L.R. Juneja, D.-C. Chu, T. Okubo, Y. Nagato, H. Yokogoshi, Trends Food Sci. Technol. 10 (1999) 199–204.
[2] T. Terashima, J. Takido, H. Yokogoshi, Biosci. Biotechnol. Biochem. 63 (1999) 615–618.
[3] A. Higashiyama, H.H. Htay, M. Ozeki, L.R. Juneja, M.P. Kapoor, J. Funct. Foods 3 (2011) 171–178.
[4] S. Hidese, M. Ota, C. Wakabayashi, T. Noda, H. Ozawa, T. Okubo, H. Kunugi, Acta Neuropsychiatr. 29 (2017) 72–79.
[5] S.-K. Park, I.-C. Jung, W.K. Lee, Y.S. Lee, H.K. Park, H.J. Go, K. Kim, N.K. Lim, J.T. Hong, S.Y. Ly, S.S. Rho, J. Med. Food 14 (2011) 334–343.
[6] A. Takeda, K. Sakamoto, H. Tamano, K. Fukura, N. Inui, S.W. Suh, S.-J. Won, H. Yokogoshi, Cell. Mol. Neurobiol. 31 (2011) 1079–1088.
[7] T.I. Kim, Y.K. Lee, S.G. Park, I.S. Choi, J.O. Ban, H.K. Park, S.-Y. Nam, Y.W. Yun, S.B. Han, K.W. Oh, J.T. Hong, Free Radic. Biol. Med. 47 (2009) 1601–1610.
[8] K. Unno, K. Fujitani, N. Takamori, F. Takabayashi, K.-I. Maeda, H. Miyazaki, N. Tanida, K. Iguchi, K. Shimoi, M. Hoshino, Free Radic. Res. 45 (2011) 966–974.
[9] S. Hidese, S. Ogawa, M. Ota, I. Ishida, Z. Yasukawa, M. Ozeki, H. Kunugi, Nutrients 11 (2019).
[10] C.H. Song, J.H. Jung, J.S. Oh, K.S. Kim, Korean Journal of Nutrition 36 (2003) 918–923.
[11] M. Gomez-Ramirez, B.A. Higgins, J.A. Rycroft, G.N. Owen, J. Mahoney, M. Shpaner, J.J. Foxe, Clin. Neuropharmacol. 30 (2007) 25–38.
[12] A.C. Nobre, A. Rao, G.N. Owen, Asia Pac. J. Clin. Nutr. 17 Suppl 1 (2008) 167–168.
[13] D.J. White, S. de Klerk, W. Woods, S. Gondalia, C. Noonan, A.B. Scholey, Nutrients 8 (2016).
[14] S. Ogawa, M. Ota, J. Ogura, K. Kato, H. Kunugi, Psychopharmacology 235 (2018) 37–45.
[15] H. Yokogoshi, M. Kobayashi, M. Mochizuki, T. Terashima, Neurochem. Res. 23 (1998) 667–673.
[16] T. Yamada, T. Terashima, T. Okubo, L.R. Juneja, H. Yokogoshi, Nutr. Neurosci. 8 (2005) 219–226.
[17] T. Yamada, T. Terashima, S. Kawano, R. Furuno, T. Okubo, L.R. Juneja, H. Yokogoshi, Amino Acids 36 (2009) 21–27.
[18] J. Yao, X.-N. Shen, H. Shen, M. Wu, Zhonghua Yu Fang Yi Xue Za Zhi 46 (2012) 635–639.
[19] M. Shen, Y. Yang, Y. Wu, B. Zhang, H. Wu, L. Wang, H. Tang, J. Chen, Phytotherapy Research 33 (2019) 412–421.
[20] G. Zhu, S. Yang, Z. Xie, X. Wan, Neuropharmacology 138 (2018) 331–340.
[21] P.J. Nathan, K. Lu, M. Gray, C. Oliver, J. Herb. Pharmacother. 6 (2006) 21–30.
[22] H. Yokogoshi, M. Kobayashi, M. Mochizuki, T. Terashima, Neurochemical Research 23 (1998) 667–673.
[23] T. Kakuda, A. Nozawa, A. Sugimoto, H. Niino, Biosci. Biotechnol. Biochem. 66 (2002) 2683–2686.
[24] C. Wakabayashi, T. Numakawa, M. Ninomiya, S. Chiba, H. Kunugi, Psychopharmacology 219 (2012) 1099–1109.
[25] C. Miodownik, R. Maayan, Y. Ratner, V. Lerner, L. Pintov, M. Mar, A. Weizman, M.S. Ritsner, Clin. Neuropharmacol. 34 (2011) 155–160.
[26] X. Tian, L. Sun, L. Gou, X. Ling, Y. Feng, L. Wang, X. Yin, Y. Liu, Brain Res. 1503 (2013) 24–32.
[27] T. Sumathi, D. Asha, G. Nagarajan, A. Sreenivas, R. Nivedha, Environ. Toxicol. Pharmacol. 42 (2016) 99–117.
[28] M. Takeshima, I. Miyazaki, S. Murakami, T. Kita, M. Asanuma, J. Clin. Biochem. Nutr. 59 (2016) 93–99.
[29] K. Lu, M.A. Gray, C. Oliver, D.T. Liley, B.J. Harrison, C.F. Bartholomeusz, K.L. Phan, P.J. Nathan, Human Psychopharmacology: Clinical and Experimental 19 (2004) 457–465.
[30] M.S. Ritsner, C. Miodownik, Y. Ratner, T. Shleifer, M. Mar, L. Pintov, V. Lerner, J. Clin. Psychiatry 72 (2011) 34–42.
[31] K. Unno, N. Tanida, N. Ishii, H. Yamamoto, K. Iguchi, M. Hoshino, A. Takeda, H. Ozawa, T. Ohkubo, L.R. Juneja, H. Yamada, Pharmacol. Biochem. Behav. 111 (2013) 128–135.
[32] A. Yoto, M. Motoki, S. Murao, H. Yokogoshi, J. Physiol. Anthropol. 31 (2012) 28.
[33] K. Kimura, M. Ozeki, L.R. Juneja, H. Ohira, Biol. Psychol. 74 (2007) 39–45.
[34] H. Tamano, K. Fukura, M. Suzuki, K. Sakamoto, H. Yokogoshi, A. Takeda, Brain Res. Bull. 95 (2013) 1–6.
[35] M. Ozeki, L.R. Juneja, S. Shirakawa, J. Physiol. Anthropol. 23 (2004) 58.
[36] M.R. Lyon, M.P. Kapoor, L.R. Juneja, Altern. Med. Rev. 16 (2011) 348–354.
[37] H.-S. Jang, J.Y. Jung, I.-S. Jang, K.-H. Jang, S.-H. Kim, J.-H. Ha, K. Suk, M.-G. Lee, Pharmacology Biochemistry and Behavior 101 (2012) 217–221.
[38] S. Kurihara, T. Hiraoka, M. Akutsu, E. Sukegawa, M. Bannai, S. Shibahara, J. Amino Acids 2010 (2010) 307475.
[39] K. Matsumoto, H. Yamada, N. Takuma, H. Niino, Y.M. Sagesaka, BMC Complement. Altern. Med. 11 (2011) 15.
[40] C.A. Rowe, M.P. Nantz, J.F. Bukowski, S.S. Percival, Journal of the American College of Nutrition 26 (2007) 445–452.
[41] S. Kawada, K. Kobayashi, M. Ohtani, C. Fukusaki, J. Strength Cond. Res. 24 (2010) 846–851.
[42] A. Juszkiewicz, A. Glapa, P. Basta, E. Petriczko, K. Żołnowski, B. Machaliński, J. Trzeciak, K. Łuczkowska, A. Skarpańska-Stejnborn, J. Int. Soc. Sports Nutr. 16 (2019) 7.
[43] S. Murakami, S. Kurihara, C.A. Titchenal, M. Ohtani, J. Int. Soc. Sports Nutr. 7 (2010) 23.
[44] S. Murakami, S. Kurihara, N. Koikawa, A. Nakamura, K. Aoki, H. Yosigi, K. Sawaki, M. Ohtani, Biosci. Biotechnol. Biochem. 73 (2009) 817–821.
[45] M. Lei, J. Zuo, M. Li, Q. Gu, C. Hu, Chin. Med. J. 127 (2014) 1545–1549.
[46] N.H. Kim, H.J. Jeong, H.M. Kim, Amino Acids 42 (2012) 1609–1618.
[47] C. Li, H. Tong, Q. Yan, S. Tang, X. Han, W. Xiao, Z. Tan, Med. Sci. Monit. 22 (2016) 662–669.
[48] C. Li, Q. Yan, S. Tang, W. Xiao, Z. Tan, Biomed Res. Int. 2018 (2018) 1497097.
[49] A.B. Kamath, L. Wang, H. Das, L. Li, V.N. Reinhold, J.F. Bukowski, Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6009–6014.
[50] J.F. Bukowski, S.S. Percival, Nutr. Rev. 66 (2008) 96–102.
[51] S. Kurihara, S. Shibahara, H. Arisaka, Y. Akiyama, J. Vet. Med. Sci. 69 (2007) 1263–1270.
[52] T. Miyachi, T. Tsuchiya, A. Oyama, T. Tsuchiya, N. Abe, A. Sato, Y. Chiba, S. Kurihara, T. Shibakusa, T. Mikami, JPEN J. Parenter. Enteral Nutr. 37 (2013) 384–391.
[53] K. Miyagawa, Y. Hayashi, S. Kurihara, A. Maeda, Geriatr. Gerontol. Int. 8 (2008) 243–250.
[54] Y. Takagi, S. Kurihara, N. Higashi, S. Morikawa, T. Kase, A. Maeda, H. Arisaka, S. Shibahara, Y. Akiyama, J. Vet. Med. Sci. 72 (2010) 157–165.
[55] M. Saeed, X. Yatao, Z. Tiantian, R. Qian, S. Chao, Poult. Sci. 98 (2019) 842–854.
[56] Q. Yan, H. Tong, S. Tang, Z. Tan, X. Han, C. Zhou, Biomed Res. Int. 2017 (2017) 9747256.
[57] K. Zarse, S. Jabin, M. Ristow, Eur. J. Nutr. 51 (2012) 765–768.
[58] C.F. Haskell, D.O. Kennedy, A.L. Milne, K.A. Wesnes, A.B. Scholey, Biol. Psychol. 77 (2008) 113–122.
[59] S.J.L. Einöther, V.E.G. Martens, J.A. Rycroft, E.A. De Bruin, Appetite 54 (2010) 406–409.
[60] T. Giesbrecht, J.A. Rycroft, M.J. Rowson, E.A. De Bruin, Nutr. Neurosci. 13 (2010) 283–290.
[61] G.N. Owen, H. Parnell, E.A. De Bruin, J.A. Rycroft, Nutr. Neurosci. 11 (2008) 193–198.
[62] S. Kim, K. Jo, K.-B. Hong, S.H. Han, H.J. Suh, Pharm. Biol. 57 (2019) 65–73.
[63] S. Kurihara, T. Shibakusa, K.A. Tanaka, Springerplus 2 (2013) 635.